|Donor-specific antibodies to class II antigens are associated with accelerated cardiac allograft vasculopathy: a three-dimensional volumetric intravascular ultrasound study.|
|PMID: 23325007 Owner: NLM Status: MEDLINE|
|BACKGROUND: Although a link between donor-specific antibodies against human leukocyte antigens type II (DSA II+) and transplant glomerulopathy has been clearly established, its role in cardiac allograft vasculopathy (CAV) is unclear.
METHODS: Donor-specific antibodies were evaluated using solid-phase single-antigen bead assay before transplantation in 51 heart transplant recipients. Coronary angiography and three-dimensional intravascular ultrasound were performed at baseline and approximately 1 year after the baseline examination.
RESULTS: There were 4 (7.8 %), 11 (21.5%), and 2 (3.9%) patients who had DSA against donor class I (DSA I+), DSA II+, or both, respectively. All patients had negative complement-dependent cytotoxic crossmatch. There was accelerated progression of CAV in the DSA II+ group demonstrated by accelerated progression in plaque index (plaque volume/vessel volume) compared to patients with no DSA II+ antibodies (13.8% [12%] vs. -7.9% [37%], P=0.01). The development of any angiographic CAV was also more common in DSA II+ patients as compared to the DSA- patients at 4 years (100% [0%] vs. 64.2% [10%], P=0.05). All other traditional risk factors for CAV or immunosuppression were similar between the groups (P>0.2 for all).
CONCLUSIONS: This is the first preliminary study demonstrating that heart transplant recipients with preformed class II DSA may be at an increased risk for accelerated CAV as detected by consecutive volumetric three-dimensional intravascular ultrasound.
|Yan Topilsky; Manish J Gandhi; Tal Hasin; Laurie L Voit; Eugenia Raichlin; Barry A Boilson; John A Schirger; Brooks S Edwards; Alfredo L Clavell; Richard J Rodeheffer; Robert P Frantz; Sudhir S Kushwaha; Amir Lerman; Naveen L Pereira|
Related Documents :
|8865247 - End-stage renal disease of the tunisian child: epidemiology, etiologies, and outcome.
23242807 - Donor-transmitted malignancy in a liver transplant recipient: a case report and review ...
11570137 - Infections in patients with end-stage renal disease. an overview.
23900887 - Impact of donor and recipient cyp3a5 and abcb1 genetic polymorphisms on tacrolimus dosa...
9692847 - Flow cytometric analysis of urine lymphocytes isolated from patients with renal transpl...
18580247 - Scintigraphic demonstration of transplant perfusion compromise with calyceal reflux.
|Type: Journal Article; Research Support, N.I.H., Extramural|
|Title: Transplantation Volume: 95 ISSN: 1534-6080 ISO Abbreviation: Transplantation Publication Date: 2013 Jan|
|Created Date: 2013-01-17 Completed Date: 2013-03-07 Revised Date: 2014-01-28|
Medline Journal Info:
|Nlm Unique ID: 0132144 Medline TA: Transplantation Country: United States|
|Languages: eng Pagination: 389-96 Citation Subset: IM|
|APA/MLA Format Download EndNote Download BibTex|
Biological Markers / blood
Coronary Artery Disease / blood, immunology*, radiography, ultrasonography*
Heart Transplantation / immunology*
Histocompatibility Antigens Class II / immunology*
Image Processing, Computer-Assisted
Immunosuppressive Agents / therapeutic use
Isoantibodies / blood*
Predictive Value of Tests
|HL 84904/HL/NHLBI NIH HHS; KL2 RR024151/RR/NCRR NIH HHS; KL2RR024151/RR/NCRR NIH HHS; UL1RR24150/RR/NCRR NIH HHS|
|0/Biological Markers; 0/Histocompatibility Antigens Class II; 0/Immunosuppressive Agents; 0/Isoantibodies|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Liver regeneration and venous collateral formation in the right lobe living-donor remnant: segmenta...
Next Document: Neospora caninum causes severe economic losses in cattle in the humid pampa region of Argentina.